“Radioimmunoassay And Enzyme-Linked Immunoassay of Antibodies Directed Against Lymphadenopathy-Associated Virus (LAV) Proteins Larger Than The Core Protein (P24)”, Neurath et al., Journal of Virological Methods, 12, 85-92 (1985).* |
“Nucleotide Sequence of The AIDS Virus, LAV”, Wain-Hobson et al., Cell, 40, 9-17 (1985).* |
“Genomic Diversity of Human T-Lymphotropic Virus Type III (HTLV-III)”, Wong-Staal et al., Science, 229, 759-762 (1985).* |
“Isolation of Human T-Lymphotropic Retrovirus (LAV) from Zairian Married Couple, One With AIDS, One With Prodromes”, Ellrodt et al., The Lancet, 1383-1385 (1984).* |
Complete Nucleotide Sequence of The AIDS Virus, HTLV-III, Ratner et al., Nature, 323, 277-284 (1985).* |
“Nucleotide Sequence and Expression of An AIDS-Associated Retrovirus (ARV-2)”, Sanchez-Pescador et al., Science, 227, 484-492 (1985).* |
“Nucleic Acid Structure and Expression Of The Human AIDS/lymphadenopathy Retrovirus”, Muesing et al., Nature, 313; 450-458 (1985).* |
“Molecule cloning of lymphadenopathy-associated virus”; Alizon et al., Nature, 312, 757-760 (1984).* |
Nature, 313, 277-284 (1985).* |
Gallo et al., 1988, Nature (London) 333:564.* |
Levy, 1993, Microbiol. Rev. 57:183-187, 211-213.* |
Los Alamos Database, 1990, in Human Retroviruses and AIDS, Myers et al., eds., Los Alamos National Laboratory, New Mexico, pp. IA1-IA3.* |
Norrby et al., 1988, “Type-specific site-directed human immunodeficiency virus serology”, in Vaccines 88, Cold Spring Harbor Laboratory, pp. 335-339.* |
Strongin, 1992, “Sensitivity, specificity, and predictive value of diagnostic tests: definitions and clinical applications”, in Laboratory Diagnosis of Viral Infections, Lennette, ed., Marcel Dekker, Inc. New York, pp. 211-219.* |
Goodenow et al., 1989, J. Acquir. Immune Defic. Syndr. 2:344-352.* |
Gao et al., 1994, J. Virol. 68:7433-7447. |